UFP Technologies to Present at Raymond James Conference

Medical device manufacturer to host investor meetings at annual event in Orlando.

Published on Feb. 27, 2026

UFP Technologies, Inc., a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, announced that Chairman and CEO R. Jeffrey Bailly and CFO Ron Lataille will participate in the upcoming Raymond James 47th Annual Institutional Investors Conference in Orlando, Florida from March 1-4, 2026. UFP's presentation is scheduled for 2:50 PM on Tuesday, March 3rd and will be available via live webcast.

Why it matters

As a vital link in the medical device supply chain, UFP's participation in this high-profile investor conference signals the company's continued growth and importance in the medical manufacturing sector. The event provides an opportunity for UFP to showcase its capabilities and attract new business opportunities.

The details

UFP Technologies is a contract development and manufacturing organization that specializes in producing single-use and single-patient medical devices and components used in a wide range of medical applications. The company's participation in the Raymond James conference includes a formal presentation as well as one-on-one investor meetings.

  • The Raymond James 47th Annual Institutional Investors Conference will be held from March 1-4, 2026 in Orlando, Florida.
  • UFP Technologies' presentation is scheduled for 2:50 PM on Tuesday, March 3rd, 2026.

The players

UFP Technologies, Inc.

A contract development and manufacturing organization that specializes in single-use and single-patient medical devices.

R. Jeffrey Bailly

Chairman and Chief Executive Officer of UFP Technologies.

Ron Lataille

Chief Financial Officer of UFP Technologies.

Got photos? Submit your photos here. ›

What’s next

The live webcast of UFP's presentation at the Raymond James conference will be available for investors to view.

The takeaway

UFP Technologies' participation in the high-profile Raymond James investor conference underscores the company's importance as a leading contract manufacturer of specialized medical devices and components. The event provides an opportunity for UFP to showcase its capabilities and attract new business opportunities in the growing medical device industry.